(Q43698639)

26 November 2017

Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic (English)

1 reference

26 November 2017

R Satchi

6

0 references

author name string

R Duncan

1

1 reference

26 November 2017

S Gac-Breton

2

1 reference

26 November 2017

R Keane

3

1 reference

26 November 2017

R Musila

4

1 reference

26 November 2017

Y N Sat

5

1 reference

26 November 2017

F Searle

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Journal of Controlled Release

26 November 2017

1 reference

26 November 2017

74

1 reference

26 November 2017

135-146

1 reference

26 November 2017

1-3

1 reference

Drug-polymer conjugates: potential for improved chemotherapy

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Polymer-bound camptothecin: initial biodistribution and antitumour activity studies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Drug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol) ester transport forms

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l-leucyldoxorubicin and its metabolites in a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

1 reference

7 January 2021

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

Poly(amidoamine)s as potential endosomolytic polymers: evaluation in vitro and body distribution in normal and tumour-bearing animals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2801%2900328-5

7 January 2021

10.1016/S0168-3659(01)00328-5

Identifiers

DOI

1 reference

26 November 2017

1 reference